about
New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseAlterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters.High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes.Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channelsAssociation of versican turnover with all-cause mortality in patients on haemodialysis.Association of systemic collagen type IV formation with survival among patients undergoing hemodialysis.Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.Evidence of perturbed germinal center dynamics, but preserved antibody diversity, in end-stage renal disease.Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels.Role of leptin in reverse epidemiology in chronic kidney disease.Expression of the NRF2 Target Gene NQO1 Is Enhanced in Mononuclear Cells in Human Chronic Kidney Disease.Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy.Increased arterial vascular tone during the night in patients with essential hypertension.Green urine following exposure to flupirtine.Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.Superoxide dismutase type 1 in monocytes of chronic kidney disease patients.Effect of renal replacement therapy on retinol-binding protein 4 isoforms.Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels.Do cysteine residues regulate transient receptor potential canonical type 6 channel protein expression?Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5.Mortality risk in hemodialysis patients with increased arterial stiffness is reduced by attainment of classical clinical performance measures.Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines.Low serum leptin predicts mortality in patients with chronic kidney disease stage 5.Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension.Transient receptor potential channels in essential hypertension.Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans.Oxidative Stress in Chronic Kidney Disease.Percutaneous catheter drainage of emphysematous pyelonephritis.Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.Soluble α-Klotho and Its Relation to Kidney Function and Fibroblast Growth Factor-23Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy[Hyponatremia]N-acetylcysteine improves arterial vascular reactivity in patients with chronic kidney diseaseHigher serum levels of free ĸ plus λ immunoglobulin light chains ameliorate survival of hemodialysis patientsErythropoietin increases expression and function of transient receptor potential canonical 5 channelsLow expression of thiosulfate sulfurtransferase (rhodanese) predicts mortality in hemodialysis patientsAcute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation
P50
Q26739475-8F06CACC-4EC0-4C93-A8B6-4F03DB75DD54Q33526141-87F968CB-5D86-4050-92CC-4BE012D6C26FQ33750707-F3A731DF-B723-4013-9B35-A62D9BC2D8A8Q34206083-6ED6B750-78F6-4708-946E-DE285714E62FQ34420828-B853CB35-D90A-4899-AEFE-4E0509906B28Q34976972-86E8777C-7961-4CA7-9643-52DB9EB439EFQ36604574-31A10D33-E615-4DE2-B7B2-D43108354F15Q36933665-B606F88D-C49D-405F-91D1-99B63E980C6FQ36975482-74480998-64D4-4193-9ECA-7029C74863A9Q36996687-7374D1A0-89DE-4744-87A6-4BC540EAB017Q38635855-5C0C9C5D-71DD-4667-9D90-7432C64768CBQ39388008-DA20123D-6FEF-4877-BC42-9317A4C3798FQ39770819-CE74E7C7-BD41-426C-B330-90C0FE02C795Q42849850-3D318617-85F0-40E6-84B7-22B883FB218EQ44451027-61691BF5-6F35-4AC8-A1C8-DAA70FEE4DE1Q44734599-B2A91CCF-E71A-4519-9AED-B6F36FA70D6BQ45916695-183D76D8-1ADE-4DFE-9F85-45C0FE5623CFQ46220626-0579CDB6-C6B8-4FA6-82DE-C25A9E0C1B26Q46290245-1F59D5C6-9262-4C24-AD61-BDD1B6FE12EEQ46975912-50A402D0-304D-4F76-BEFA-508BB8FA755DQ52892377-6D9F1883-DC82-4FBF-A8EC-B73C8DE316F5Q52910489-E42B3294-F097-43B8-B126-EEEDB287274DQ52913370-75FE6C6D-366A-4EC4-A59A-353CBF7EC3ADQ52921130-E86E22E7-3BD4-4230-9A37-18F3A14FF2B2Q52925688-8F4DE9AA-D78F-4D97-A5B9-5D14154D453BQ52927054-8C6A0BE3-C0EA-4E49-984E-F2C2B9CDCE00Q52933025-F2B7514A-0886-4151-87F2-20C3FC0EA6DDQ52936392-7E93CFD0-8930-49CB-9CD8-451D06E42672Q53037437-D7A60DF2-E92B-4AF7-A460-B221734945D3Q53546207-83261A6C-8972-41CE-AC93-C5970340C5BAQ55412511-D7A2C2C0-74B3-49CD-8C76-8255C80918AFQ57570867-0C792A77-8350-47A1-8D80-3F17C12D0342Q80593814-845E5E3E-2BC4-47EA-8295-906398B84B59Q83395273-2AF1C964-1128-44DC-8CFB-90B441FFA38DQ83825132-241D3F02-EFF8-412E-9B49-37564A48E690Q84288630-0222A170-6E6B-446D-9C9E-FBBEE706BE56Q84401645-F24BFF78-EC74-486F-92FB-B409590DB9EAQ84439131-C3D2DE7E-94A4-4D70-A990-9785773C327FQ85059499-121D343B-7CA9-40D3-928C-0A0A95331F39
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexandra Scholze
@ast
Alexandra Scholze
@en
Alexandra Scholze
@es
Alexandra Scholze
@nl
Alexandra Scholze
@sl
type
label
Alexandra Scholze
@ast
Alexandra Scholze
@en
Alexandra Scholze
@es
Alexandra Scholze
@nl
Alexandra Scholze
@sl
prefLabel
Alexandra Scholze
@ast
Alexandra Scholze
@en
Alexandra Scholze
@es
Alexandra Scholze
@nl
Alexandra Scholze
@sl
P106
P1153
9041653600
P21
P2798
P31
P496
0000-0002-3100-8692